Amarin Corp PLC (AMRN)

3.605 -0.08  -2.30% NASDAQ Dec 8, 16:00 3.605 0.00  0.00% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All AMRN News

News

View All Events

Events

Date Type Description
02/25/2022 07:30 EST Earnings Calls Q4 2021 Earnings Call
02/24/2022 Earnings Results Q4 2021 Earnings Results
11/03/2021 Earnings Results Q3 2021 Earnings Results
11/03/2021 07:30 EST Earnings Calls Q3 2021 Earnings Call
08/05/2021 Earnings Results Q2 2021 Earnings Results
08/05/2021 07:30 EST Earnings Calls Q2 2021 Earnings Call
06/14/2021 09:00 EST AGM 2020 Annual General Meeting
04/29/2021 Earnings Results Q1 2021 Earnings Results
04/29/2021 07:30 EST Earnings Calls Q1 2021 Earnings Call
02/25/2021 07:30 EST Earnings Calls Q4 2020 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa.
  • URL: https://www.amarincorp.com
  • Investor Relations URL: https://investor.amarincorp.com/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Feb. 24, 2022
  • Last Earnings Release: Nov. 03, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
SBVLX ClearBridge Small Cap Value C 1.49%
LGASX ClearBridge Small Cap FI 1.28%
MYIFX Monetta Young Investor Growth 1.25%
PPH VanEck Pharmaceutical ETF 0.54%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.